# Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects.

> **NCT03520348** · PHASE1 · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 24 (actual)

## Conditions studied

- Dry Eye
- Dry Eye Syndrome of Unspecified Lacrimal Gland

## Interventions

- **DRUG:** PRO-167
- **DRUG:** Corneregel

## Key facts

- **NCT ID:** NCT03520348
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-04
- **Primary completion:** 2018-05-22
- **Final completion:** 2018-07-16
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03520348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03520348, "Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03520348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*